1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Comorbidities of participantsa
Study Group NPH HC-M HC-Y Arterial hypertension 5/10 6/18 0/14 Arteriovenous malformation 0/10 0/18 2/14 Atrial fibrillation 0/10 2/18 0/14 Headaches 0/10 1/18 1/14 Coronary heart disease 2/10 0/18 0/14 Dizziness 1/10 0/18 0/14 Meningiomab 0/10 1/18 0/14 Microangiopathy 1/10 1/18 0/14 Multiple sclerosis 0/10 0/18 4/14 Orthostatic tremor 1/10 0/18 0/14 Peripheral arterial disease 1/10 0/18 0/14 Restless leg syndrome 0/10 1/18 0/14 Seizure disorder 1/10 0/18 1/14 Prior stroke 1/10 3/18 0/14 History of syncope 0/10 1/18 0/14 History of transient ischemic attack 0/10 2/18 0/14